Search Results - "CARAPETIS, J. R."
-
1
Case-Control Evaluation of the Effectiveness of the G1P[8] Human Rotavirus Vaccine during an Outbreak of Rotavirus G2P[4] Infection in Central Australia
Published in Clinical infectious diseases (15-01-2011)“…The human rotavirus vaccine was evaluated during an outbreak of rotavirus G2P[4] infection in central Australia. No overall protective effect against…”
Get full text
Journal Article -
2
Environmental and social determinants of acute rheumatic fever: a longitudinal cohort study
Published in Epidemiology and infection (01-01-2019)“…Acute rheumatic fever (ARF), an auto-immune response to a group A Streptococcus infection and precursor to rheumatic heart disease (RHD), remains endemic in…”
Get full text
Journal Article -
3
The high prevalence and impact of rheumatic heart disease in pregnancy in First Nations populations in a high‐income setting: a prospective cohort study
Published in BJOG : an international journal of obstetrics and gynaecology (01-01-2020)“…Objective To describe the epidemiology of rheumatic heart disease (RHD) in pregnancy in Australia and New Zealand (A&NZ). Design Prospective population‐based…”
Get full text
Journal Article -
4
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial
Published in Vaccine (26-04-2010)“…Abstract Background To evaluate the immunological impact of the 23-valent pneumococcal polysaccharide vaccine (23vPPS) at 12 months, for children who have…”
Get full text
Journal Article -
5
Echocardiographic screening in a resource poor setting: Borderline rheumatic heart disease could be a normal variant
Published in International journal of cardiology (01-05-2014)“…Abstract Objective To estimate the echocardiography confirmed prevalence of rheumatic heart disease (RHD) in school children in Fiji. Design Cross-sectional…”
Get full text
Journal Article -
6
Pneumococcal Nasopharyngeal Carriage following Reduced Doses of a 7-Valent Pneumococcal Conjugate Vaccine and a 23-Valent Pneumococcal Polysaccharide Vaccine Booster
Published in Clinical and Vaccine Immunology (01-12-2010)“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
7
Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine
Published in Vaccine (18-09-2009)“…Abstract The aim was to identify an appropriate infant pneumococcal vaccination strategy for resource poor countries. Fijian infants received zero, one, two,…”
Get full text
Journal Article -
8
As a Bacterial Culture Medium, Citrated Sheep Blood Agar Is a Practical Alternative to Citrated Human Blood Agar in Laboratories of Developing Countries
Published in Journal of Clinical Microbiology (01-09-2006)“…Human blood agar (HuBA) is widely used in developing countries for the isolation of bacteria from clinical specimens. This study compared citrated sheep blood…”
Get full text
Journal Article -
9
The fall and rise of Group A Streptococcus diseases
Published in Epidemiology and infection (01-01-2019)“…Streptococcus pyogenes (or Group A Streptococcus, GAS) is a Gram-positive human pathogen responsible for a diverse array of superficial, invasive and…”
Get full text
Journal Article -
10
Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age
Published in Vaccine (10-01-2011)“…Abstract Opsonophagocytic activity (OPA) was measured following reduced infant doses of 7-valent pneumococcal conjugate vaccine (PCV-7) with or without…”
Get full text
Journal Article -
11
Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy
Published in Vaccine (19-04-2010)“…Abstract Fijian infants aged 6 weeks were stratified by ethnicity and randomized to receive 0, 1, 2, or 3 PCV-7 doses with or without the 23-valent…”
Get full text
Journal Article -
12
Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months
Published in Vaccine (15-06-2011)“…Abstract Aim To evaluate whether the avidity of serotype-specific IgG to pneumococcal serotypes is enhanced by an increased number of doses of the 7-valent…”
Get full text
Journal Article -
13
Systematic review of rheumatic heart disease prevalence in children in developing countries: The role of environmental factors
Published in Journal of paediatrics and child health (01-06-2002)“…Objectives: To consider the worldwide prevalence of rheumatic heart disease in children in developing countries using surveys with uniform methodologies, and…”
Get full text
Journal Article -
14
Rheumatic fever in a high incidence population: the importance of monoarthritis and low grade fever
Published in Archives of disease in childhood (01-09-2001)“…AIMS To describe the clinical features of rheumatic fever and to assess the Jones criteria in a population and setting similar to that in many developing…”
Get full text
Journal Article -
15
Molecular typing of Streptococcus pyogenes from remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infection
Published in Epidemiology and infection (01-11-2007)“…Aboriginal Australians in remote communities have high rates of rheumatic heart disease (RHD); yet pharyngitis is reportedly rare whilst pyoderma is common…”
Get full text
Journal Article -
16
Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections
Published in Clinical infectious diseases (01-08-2014)“…Background. The use of clindamycin and intravenous immunoglobulin (IVIG) in treatment of invasive group A streptococcal (iGAS) infection, and the need for…”
Get full text
Journal Article -
17
High burden of invasive β-haemolytic streptococcal infections in Fiji
Published in Epidemiology and infection (01-05-2008)“…We undertook a 5-year retrospective study of group A streptococcal (GAS) bacteraemia in Fiji, supplemented by a 9-month detailed retrospective study of…”
Get full text
Journal Article -
18
Preliminary validation of a novel high-resolution melt-based typing method based on the multilocus sequence typing scheme of Streptococcus pyogenes
Published in Clinical microbiology and infection (01-09-2011)“…The major limitation of current typing methods for Streptococcus pyogenes, such as emm sequence typing and T typing, is that these are based on regions subject…”
Get full text
Journal Article -
19
The dynamic nature of group A streptococcal epidemiology in tropical communities with high rates of rheumatic heart disease
Published in Epidemiology and infection (01-04-2008)“…Prospective surveillance was conducted in three remote Aboriginal communities with high rates of rheumatic heart disease in order to investigate the…”
Get full text
Journal Article -
20
Cumulative incidence of rheumatic fever in an endemic region: a guide to the susceptibility of the population?
Published in Epidemiology and infection (01-04-2000)“…Aboriginal Australians in northern Australia are subject to endemic infection with group A streptococci, with correspondingly high rates of acute rheumatic…”
Get full text
Journal Article